TLY-012

N/A

Report date: 2025/04/30 11:21:16

Base Information

Drug NameTLY-012
Drug Alias NameTLY-012
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionTumor necrosis factor receptor superfamily member 10B agonists
TargetsTumor necrosis factor receptor superfamily member 10B
Therapy Area/IndicationsFibrosisScleroderma, SystemicPancreatitis, Chronic +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTheraly Fibrosis
China Registration ClassN/A

Develop Information

Active CompaniesTheraly FibrosisD&D Pharmatech
Inactive CompaniesN/A
Active IndicationsFibrosisScleroderma, SystemicPancreatitis, Chronic +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A